C.E. Spivak

1.4k total citations
18 papers, 1.2k citations indexed

About

C.E. Spivak is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, C.E. Spivak has authored 18 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 2 papers in Pharmacology. Recurrent topics in C.E. Spivak's work include Ion channel regulation and function (11 papers), Nicotinic Acetylcholine Receptors Study (10 papers) and Receptor Mechanisms and Signaling (7 papers). C.E. Spivak is often cited by papers focused on Ion channel regulation and function (11 papers), Nicotinic Acetylcholine Receptors Study (10 papers) and Receptor Mechanisms and Signaling (7 papers). C.E. Spivak collaborates with scholars based in United States, United Kingdom and Bulgaria. C.E. Spivak's co-authors include George R. Uhl, E X Albuquerque, Yasuo Imai, C. Mark Eppler, Paul Gregor, Serdar Demirgören, Monika Majewska, Edythe D. London, Bernhard Witkop and Valina L. Dawson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, American Journal of Respiratory and Critical Care Medicine and FEBS Letters.

In The Last Decade

C.E. Spivak

17 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C.E. Spivak United States	14	864	699	135	86	79	18	1.2k
J.M. Sarvey United States	18	704 0.8×	1.2k 1.8×	170 1.3×	36 0.4×	56 0.7×	24	1.7k
George M. Ling Canada	22	401 0.5×	433 0.6×	170 1.3×	42 0.5×	58 0.7×	67	1.3k
Ian A. Pullar United Kingdom	21	469 0.5×	592 0.8×	102 0.8×	177 2.1×	42 0.5×	38	1.1k
Aase Frandsen Denmark	23	1.1k 1.3×	1.3k 1.9×	253 1.9×	38 0.4×	24 0.3×	41	2.0k
Frederick H. Leitz United States	9	639 0.7×	706 1.0×	81 0.6×	82 1.0×	33 0.4×	10	1.2k
Wamberto Antônio Varanda Brazil	22	584 0.7×	255 0.4×	160 1.2×	42 0.5×	27 0.3×	54	1.2k
Jean Schwartz France	21	605 0.7×	544 0.8×	192 1.4×	158 1.8×	15 0.2×	48	1.3k
Christopher M. de Fiebre United States	22	1.1k 1.3×	755 1.1×	231 1.7×	41 0.5×	65 0.8×	37	1.5k
D. Malthe‐Sørenssen Norway	21	612 0.7×	826 1.2×	128 0.9×	34 0.4×	43 0.5×	35	1.4k
Stanislav Tuček Czechia	25	1.4k 1.6×	1.2k 1.7×	279 2.1×	94 1.1×	19 0.2×	65	2.1k

Countries citing papers authored by C.E. Spivak

Since Specialization

Citations

This map shows the geographic impact of C.E. Spivak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.E. Spivak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.E. Spivak more than expected).

Fields of papers citing papers by C.E. Spivak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.E. Spivak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.E. Spivak. The network helps show where C.E. Spivak may publish in the future.

Co-authorship network of co-authors of C.E. Spivak

This figure shows the co-authorship network connecting the top 25 collaborators of C.E. Spivak. A scholar is included among the top collaborators of C.E. Spivak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.E. Spivak. C.E. Spivak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Spivak, C.E., et al.. (2025). Can Lightning Strike the Same Person Twice? Pseudallescheria Boydii Pneumonia and Metastatic Cardiac Angiosarcoma Within a Year. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A6722–A6722.

Kusama, Tadashi, et al.. (1993). Pharmacology of GAB A ρ1 and GAB A α/β receptors expressed in Xenopus oocytes and COS cells. British Journal of Pharmacology. 109(1). 200–206. 133 indexed citations

Garcha, H. S., Peter Thomas, C.E. Spivak, Susan Wonnacott, & Ian P. Stolerman. (1993). Behavioural and ligand-binding studies in rats with 1-acetyl-4-methylpiperazine, a novel nicotinic agonist. Psychopharmacology. 110(3). 347–354. 12 indexed citations

Imai, Yasuo, et al.. (1993). mu opiate receptor: cDNA cloning and expression.. Proceedings of the National Academy of Sciences. 90(21). 10230–10234. 335 indexed citations

Spivak, C.E., et al.. (1991). Electrophysiological and binding studies on intact NCB-20 cells suggest presence of a low affinity sigma receptor.. Journal of Pharmacology and Experimental Therapeutics. 257(1). 351–359. 64 indexed citations

Demirgören, Serdar, Monika Majewska, C.E. Spivak, & Edythe D. London. (1991). Receptor binding and electrophysiological effects of Dehydroepiandrosterone sulfate, an antagonist of the GABAA receptor. Neuroscience. 45(1). 127–135. 189 indexed citations

Gund, Tamara & C.E. Spivak. (1991). [32] Pharmacophore for nicotinic agonists. Methods in enzymology on CD-ROM/Methods in enzymology. 203. 677–693. 14 indexed citations

McManus, Owen B., C.E. Spivak, A.L. Blatz, David S. Weiss, & Karl L. Magleby. (1989). Fractal models, Markov models, and channel kinetics. Biophysical Journal. 55(2). 383–385. 27 indexed citations

Spivak, C.E., James A. Waters, & Robert S. Aronstam. (1989). Binding of semirigid nicotinic agonists to nicotinic and muscarinic receptors.. Molecular Pharmacology. 36(1). 177–184. 14 indexed citations

10.

McManus, Owen B., David S. Weiss, C.E. Spivak, A.L. Blatz, & Karl L. Magleby. (1988). Fractal models are inadequate for the kinetics of four different ion channels. Biophysical Journal. 54(5). 859–870. 70 indexed citations

11.

Reavill, C., et al.. (1987). Isoarecolone can inhibit nicotine binding and produce nicotine-like discriminative stimulus effects in rats. Neuropharmacology. 26(7). 789–792. 51 indexed citations

12.

Spivak, C.E., et al.. (1986). Structural and electronic requirements for potent agonists at a nicotinic receptor. European Journal of Pharmacology. 120(1). 127–131. 31 indexed citations

13.

Spivak, C.E. & E X Albuquerque. (1985). Triphenylmethylphosphonium blocks the nicotinic acetylcholine receptor noncompetitively.. Molecular Pharmacology. 27(2). 246–255. 11 indexed citations

14.

Spivak, C.E., M A Maleque, K. TAKAHASHI, A. BROSSI, & Edson X. Albuquerque. (1983). The ionic channel of the nicotinic acetylcholine receptor is unable to differentiate between the optical antipodes of perhydrohistrionicotoxin. FEBS Letters. 163(2). 189–193. 7 indexed citations

15.

Spivak, C.E., James A. Waters, Bernhard Witkop, & E X Albuquerque. (1983). Potencies and channel properties induced by semirigid agonists at frog nicotinic acetylcholine receptors.. Molecular Pharmacology. 23(2). 337–343. 39 indexed citations

16.

Spivak, C.E., M A Maleque, A. C. B. de Oliveira, et al.. (1982). Actions of the histrionicotoxins at the ion channel of the nicotinic acetylcholine receptor and at the voltage-sensitive ion channels of muscle membranes.. Molecular Pharmacology. 21(2). 351–361. 60 indexed citations

17.

Spivak, C.E., Bernhard Witkop, & E X Albuquerque. (1980). Anatoxin-a: A Novel, Potent Agonist at the Nicotinic Receptor. Molecular Pharmacology. 18(3). 384–394. 103 indexed citations

18.

Albuquerque, E X, Michael Adler, C.E. Spivak, & Luis G. Aguayo. (1980). MECHANISM OF NICOTINIC CHANNEL ACTIVATION AND BLOCKADE*. Annals of the New York Academy of Sciences. 358(1). 204–238. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact